Thanks for the great post that is spot on. Looking at the officers and directors of QSAM, it looks more like a NASDAQ biotech than an OTC. There is not one company in FDA Phase 1 with less than a $50 million market cap. QSAM is about $12 million. Doug Baum said publicly the Company hopes to be in FDA Phase 1 trials the first half of 2021. I'm not selling any either.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.